Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by wjon Dec 04, 2013 10:07am
160 Views
Post# 21968471

A little more info

A little more info
Bloom Burton
 
·         Bloom Burton & Co. is Canada's largest and most active healthcare-specialized investment banking group.
·         Bloom Burton performed 6 months of intense due diligence of Sirona’s Chemistry using their own scientific team.
·         Bloom Burton identified the two most exciting projects they could both finance and which had enormous market potential.
·         This agreement is the first time Bloom Burton has directly invested their own financial and scientific resources into a project.
·         The exact target molecules are not being news released until Patents are filed.
·         Bloom Burton and Sirona have negotiated a profit sharing Joint Venture which is a win-win deal that took two months to construct.
·         The teams anticipate further joint ventures based on the same structure.
Sirona
 
·         Sirona’s other LOI’s are proceeding as anticipated towards definitive agreements and management anticipates a steady flow of positive news to follow.
·         A much expanded pipeline of projects is building and this translates into multiple shots on goal.
·         Management remains confident about achieving its goals.
·         Sirona continues its evolution with management changes including its latest director Nigel Terrett.
·         Further changes are underway including management and funding sources.

wj
 
Bullboard Posts